Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GAB1 attenuates lipopolysaccharide‑mediated endothelial dysfunction via regulation of SOCS3. | Exp Ther Med | 2024 | 39171145 | PubTator, text mining | PubMed |
| Deafness DFNB128 Associated with a Recessive Variant of Human MAP3K1 Recapitulates Hearing Loss of Map3k1-Deficient Mice. | Genes (Basel) | 2024 | 39062623 | PubTator, text mining | PubMed |
| Retraction: Knockdown of Gab1 Inhibits Cellular Proliferation, Migration, and Invasion in Human Oral Squamous Carcinoma Cells. | Oncol Res | 2024 | 39055893 | PubTator, text mining | PubMed |
| Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver fibrosis via potential involvement of the HGF/c-Met signaling axis. | PLoS One | 2024 | 38935609 | PubTator, text mining | PubMed |
| Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells. | Int Immunopharmacol | 2024 | 38897121 | PubTator, text mining | PubMed |
| Molecular Subgrouping Based on Immunohistochemistry in Medulloblastoma: A Single-Center Experience. | Turk Neurosurg | 2024 | 38874255 | PubTator, text mining | PubMed |
| PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs. | Oncoscience | 2024 | 38699225 | PubTator, text mining | PubMed |
| G-Clamp Heterocycle Modification Containing Interstrand Photo-Cross-Linker to Capture Intracellular MicroRNA Targets. | J Am Chem Soc | 2024 | 38679963 | PubTator, text mining | PubMed |
| Dysregulated Gab1 signalling in triple negative breast cancer. | Cell Commun Signal | 2024 | 38448989 | PubTator, text mining | PubMed |
| Alternative splicing and related RNA binding proteins in human health and disease. | Signal Transduct Target Ther | 2024 | 38302461 | PubTator, text mining | PubMed |
| Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design. | Biomedicines | 2024 | 38275417 | PubTator, text mining | PubMed |
| Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer. | NPJ Precis Oncol | 2024 | 38273040 | PubTator, text mining | PubMed |
| Exploring the effect of LncRNA DANCR to regulate the Keap1-Nrf2/ARE pathway on oxidative stress in rheumatoid arthritis. | Immun Inflamm Dis | 2024 | 38270324 | PubTator, text mining | PubMed |
| In situ modeling of acquired resistance to RTK/RAS-pathway-targeted therapies. | iScience | 2024 | 38226159 | PubTator, text mining | PubMed |
| Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans. | EBioMedicine | 2024 | 38215691 | PubTator, text mining | PubMed |
| Brief Electrical Stimulation Promotes Recovery after Surgical Repair of Injured Peripheral Nerves. | Int J Mol Sci | 2024 | 38203836 | PubTator, text mining | PubMed |
| Genetic variations in IKZF3, LET7-a2, and CDKN2B-AS1: Exploring associations with metabolic syndrome susceptibility and clinical manifestations. | J Clin Lab Anal | 2024 | 38193570 | PubTator, text mining | PubMed |
| Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes. | Hepatol Commun | 2024 | 38180972 | PubTator, text mining | PubMed |
| Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment. | BMC Urol | 2024 | 38172792 | PubTator, text mining | PubMed |
| Signaling pathways of liver regeneration: Biological mechanisms and implications. | iScience | 2024 | 38155779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=4